Inhibition of Ezh2 redistributes bivalent domains within transcriptional regulators associated with WNT and Hedgehog pathways in osteoblasts
Journal of Biological Chemistry · 2023-09 · 299 (9) · 105155
DOI: 10.1016/j.jbc.2023.105155 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023-09. Verfasst von Margarita E Carrasco und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Enhancer of Zeste Homolog 2 Protein, Osteoblasts, Signal Transduction. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, National Institutes of Health, Agencia Nacional de Investigación y Desarrollo.
Abstract (Originalsprache)
Bivalent epigenomic regulatory domains containing both activating histone 3 lysine 4 (H3K4me3) and repressive lysine 27 (H3K27me3) trimethylation are associated with key developmental genes. These bivalent domains repress transcription in the absence of differentiation signals but maintain regulatory genes in a poised state to allow for timely activation. Previous studies demonstrated that enhancer of zeste homolog 2 (Ezh2), a histone 3 lysine 27 (H3K27) methyltransferase, suppresses osteogenic differentiation and that inhibition of Ezh2 enhances commitment of osteoblast progenitors in vitro and bone formation in vivo. Here, we examined the mechanistic effects of Tazemetostat (EPZ6438), an Food and Drug Administration approved Ezh2 inhibitor for epithelioid sarcoma treatment, because this drug could potentially be repurposed to stimulate osteogenesis for clinical indications. We find that Tazemetostat reduces H3K27me3 marks in bivalent domains in enhancers required for bone formation and stimulates maturation of MC3T3 preosteoblasts. Furthermore, Tazemetostat activates bivalent genes associated with the Wingless/integrated (WNT), adenylyl cyclase (cAMP), and Hedgehog (Hh) signaling pathways based on transcriptomic (RNA-seq) and epigenomic (chromatin immunoprecipitation [ChIP]-seq) data. Functional analyses using selective pathway inhibitors and silencing RNAs demonstrate that the WNT and Hh pathways modulate osteogenic differentiation after Ezh2 inhibition. Strikingly, we show that loss of the Hh-responsive transcriptional regulator Gli1, but not Gli2, synergizes with Tazemetostat to accelerate osteoblast differentiation. These studies establish epigenetic cooperativity of Ezh2, Hh-Gli1 signaling, and bivalent regulatory genes in suppressing osteogenesis. Our findings may have important translational ramifications for anabolic applications requiring bone mass accrual and/or reversal of bone loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
- Program in Molecular Biology and Bioinformatics, Faculty of Medicine, Center for Biomedical Research and Innovation (CIIB), Universidad de los Andes, Santiago, Chile; IMPACT, Center of Interventional Medicine for Precis…
- Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: Dudakovic.Amel@mayo.edu.
- Department of Biochemistry, University of Vermont, Burlington, Vermont, USA. Electronic address: andre.vanwijnen@uvm.edu.
Förderung
- NIAMS NIH HHS
- National Institutes of Health
- Agencia Nacional de Investigación y Desarrollo
- NIAMS
- Mayo Clinic
- University of Vermont
- Comisión Nacional de Investigación Científica y Tecnológica
- Fondo Nacional de Desarrollo Científico y Tecnológico
Zitieren
APA
Carrasco, M. E., Thaler, R., Nardocci, G., Dudakovic, A., & van Wijnen, A. J. (2023). Inhibition of Ezh2 redistributes bivalent domains within transcriptional regulators associated with WNT and Hedgehog pathways in osteoblasts. Journal of Biological Chemistry, 299(9), 105155. https://doi.org/10.1016/j.jbc.2023.105155
Vancouver
Carrasco ME, Thaler R, Nardocci G, Dudakovic A, van Wijnen AJ. Inhibition of Ezh2 redistributes bivalent domains within transcriptional regulators associated with WNT and Hedgehog pathways in osteoblasts. Journal of Biological Chemistry. 2023;299(9):105155. doi:10.1016/j.jbc.2023.105155
BibTeX
@article{Carrasco2023,
author = {Carrasco, Margarita E and Thaler, Roman and Nardocci, Gino and Dudakovic, Amel and van Wijnen, Andre J},
title = {Inhibition of Ezh2 redistributes bivalent domains within transcriptional regulators associated with WNT and Hedgehog pathways in osteoblasts},
journal = {Journal of Biological Chemistry},
year = {2023},
volume = {299},
number = {9},
pages = {105155},
doi = {10.1016/j.jbc.2023.105155}
}
EUVIMED